Products in Development
The NanOlogy therapeutic platform is embodied in patented submicron particles of pure drug designed for targeted delivery via direct injection, inhalation, instillation, or topical application.
NanoPac®
(Sterile Submicron Particle Paclitaxel for Suspension)
Ovarian Cancer (intraperitoneal)
Prostate Cancer (intratumoral)
Pancreatic Cancer (intratumoral)
Pancreatic Mucinous Cysts (intracystic)
NanoDoce®
(Sterile Submicron Particle Docetaxel for Suspension)
Bladder Cancer (local)
Renal Cancer (intratumoral)
NanoPac®
(Submicron Particle Paclitaxel for Nebulized Inhalation)
Non-Small Cell Lung Cancer (inhalation)
SOR007 Topical
(Submicron Particle Paclitaxel Suspended in Anhydrous Base)
Cutaneous Metastases
Actinic Keratosis
